You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ANTX Award Disclosure
Martin Patricia A. · SEC Form 4 · Filed Jul 10, 2026
Award
Calculated transaction value
$0
Martin Patricia A. Director
ANTX
Transaction date
Jul 10, 2026
Public filing date
Jul 10, 2026
Filing lag
Filed same day
ANTX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 766 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-301165
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| An2 Therapeutics, Inc. ANTX Current | Award | Jul 10, 2026 | $0 |